Compounds > magnesium-pyridoxal-5'-phosphate glutamate
Page last updated: 2024-09-05

magnesium-pyridoxal-5'-phosphate glutamate and Hyperlipemia

magnesium-pyridoxal-5'-phosphate glutamate has been researched along with Hyperlipemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wieland, H1
Hasford, J; Heintz, B; Kirsten, R; Nelson, K; Oremek, G; Sieberth, HG; Speck, U1

Trials

1 trial(s) available for magnesium-pyridoxal-5'-phosphate glutamate and Hyperlipemia

ArticleYear
Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency.
    European journal of clinical pharmacology, 1988, Volume: 34, Issue:2

    Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Glutamine; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxal Phosphate; Triglycerides

1988

Other Studies

1 other study(ies) available for magnesium-pyridoxal-5'-phosphate glutamate and Hyperlipemia

ArticleYear
[MPPG complex belongs in the first phase of drug-assisted lipid lowering (magnesium-pyridoxal-phosphate-glutamate )].
    Fortschritte der Medizin, 1990, Volume: 108 Spec No 1

    Topics: Glutamine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Pyridoxal Phosphate

1990